Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lipid-phase reactive oxygen species (ROS) and radicals are highly reactive chemical entities generated within the hydrophobic environment of biological membranes and lipoproteins. These species, including lipid peroxyl radicals (LOO•) and lipid hydroperoxides (LOOH), are primary drivers of lipid peroxidation, a self-propagating chain reaction that compromises membrane integrity and cellular function (Niki, 2014, Free Radic Biol Med). In lipoproteins such as low-density lipoprotein (LDL), the oxidative modification of lipids by these radicals is a hallmark of early-stage atherosclerosis and plaque formation (Steinberg, 2009, J Lipid Res). Pharmacological intervention typically involves the use of lipophilic antioxidants or chain-breaking scavengers that neutralize these radicals before they can damage structural lipids (Ayala et al., 2014, Oxid Med Cell Longev). Furthermore, the accumulation of lipid ROS is the defining feature of ferroptosis, an iron-dependent form of regulated cell death, making these species critical targets for treating neurodegeneration and certain cancers (Stockwell et al., 2017, Cell). Therapeutic strategies often focus on preventing the initiation of radical formation or terminating the propagation phase to maintain cellular homeostasis. Monitoring these species through biomarkers like malondialdehyde or isoprostanes provides insight into the systemic oxidative stress levels in patients.
Radical scavenging and chain-breaking antioxidant activity to terminate lipid peroxidation propagation.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipid-phase reactive oxygen species and radicals (Lipid ROS).